Seres Therapeutics, Inc. Contract Liability (Deferred Revenue)
Seres Therapeutics, Inc. (MCRB) had Contract Liability (Deferred Revenue) of $6.78 million as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-02
- 2020-09-30: Contract with Customer, Liability, Current $6.78M.
- 2020-06-30: Contract with Customer, Liability, Current $5.65M.
- 2020-03-31: Contract with Customer, Liability, Current $4.86M.
- 2019-12-31: Contract with Customer, Liability, Current $4.83M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $6.78M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $5.65M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $4.86M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.83M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.79M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $2.69M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $2.77M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $20.42M 10-K · filed 2019-03-06 |
| 2018-09-30 | $17.90M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $17.96M 10-Q · filed 2018-08-02 |
| 2017-12-31 | $12.08M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |